Trenbolone Acetate

Trenbolone Acetate (Tren A) is a 19-nor anabolic with a short acetate ester. It binds the androgen receptor extremely strongly - much more than testosterone - and does not aromatize to estrogen. Originally from veterinary medicine (Finaplix, cattle), it is considered one of the most potent anabolics there is.

This information is for research and educational purposes only. No medical advice.

Trenbolone activates the androgen receptor with very high affinity and massively raises protein synthesis, nitrogen retention and nutrient efficiency. It does not aromatize but has progesterone receptor activity (progestin effect) - so despite the lack of aromatization it can cause side effects via the prolactin pathway.

Intramuscular (glute, thigh), usually every other day due to the short acetate ester. The short ester makes it quickly controllable - if side effects appear, levels drop fast.

Subcutaneous is not ideal for trenbolone: the compound irritates subcutaneous tissue (nodules) and the short ester adds to that. IM preferred; subQ only very low volume and if well tolerated.

Human studies on trenbolone itself are scarce (it is primarily veterinary). The pharmacology of anabolic steroids is well documented (Kicman, Br J Pharmacol 2008; Hartgens & Kuipers, Sports Med 2004) - trenbolone's high androgen receptor affinity and lack of aromatization are described there.

• Prolactin/progestin: via progesterone activity - libido issues, possible gyno despite no aromatization. Cabergoline is the usual countermeasure.
• Night sweats, sleep issues, aggression: classic tren symptoms.
• Tren cough: brief coughing fit right after injection.
• Cardiovascular: unfavorable lipids, raised blood pressure.
• HPTA suppression: strong - PCT topic.

Store the oil solution at room temperature, protected from light - no fridge needed. Out of reach of children.